Exploration of nucleos(t)ide analogs cessation in chronic hepatitis B patients with hepatitis B e antigen loss. [PDF]
Xue Y +7 more
europepmc +1 more source
Serum Pregenomic RNA Combined With Hepatitis B Core-Related Antigen Helps Predict the Risk of Virological Relapse After Discontinuation of Nucleos(t)ide Analogs in Patients With Chronic Hepatitis B. [PDF]
Wang FD +7 more
europepmc +1 more source
Weekly HBsAg Decline Dynamics During Combination Therapy with Interferon and Nucleos(t)ide Analogs: A Retrospective Real-World Study. [PDF]
Yi Z +9 more
europepmc +1 more source
A randomized trial of viral vector and adjuvanted protein HBV therapeutic vaccine in people with chronic hepatitis B on nucleos(t)ide analogs. [PDF]
Jeng WJ +15 more
europepmc +1 more source
Synthesis of Novel d-Glucopyranuronamide-Based Nucleos(t)ide Analogs Bearing (Triazolyl)methyl Phosph(on)ate Motifs With Anticancer and Antibacterial Potential. [PDF]
Manuel DM +5 more
europepmc +1 more source
Nucleos(t)ide analogs reduce the risk of hepatitis B‐associated hepatocellular carcinoma: A can't miss proposition? [PDF]
Neil, Mehta, Francis Y, Yao
openaire +2 more sources
Editorial: Hepatitis B virus and host interactions in liver diseases
Yuen Gao, Xiao-Jie Lu, Yaoping Shi
doaj +1 more source
HBsAg isoforms predict HBsAg seroclearance and finite treatment in patients with chronic hepatitis B after cessation of long-term nucleos(t)ide analogs. [PDF]
Mak LY +9 more
europepmc +1 more source
No Immediate Need for Nucleos(t)ide Analogs Treatment in Untreated Patients With Low-Level Viremia: Evidence From Hepatitis B Virus RNA Levels. [PDF]
Zhang Y +5 more
europepmc +1 more source
Immunoglobulin, nucleos(t)ide analogs and hbv recurrence after liver transplant: a meta‐analysis
Lai, Quirino +4 more
openaire +1 more source

